These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39178066)

  • 21. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
    Steenwijk MD; Vrenken H; Jonkman LE; Daams M; Geurts JJ; Barkhof F; Pouwels PJ
    Mult Scler; 2016 Sep; 22(10):1279-88. PubMed ID: 26564997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis.
    Virgilio E; Vecchio D; Crespi I; Puricelli C; Barbero P; Galli G; Cantello R; Dianzani U; Comi C
    J Neurol; 2022 Jun; 269(6):3249-3257. PubMed ID: 35088141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.
    Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M
    Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
    Kalatha T; Arnaoutoglou M; Koukoulidis T; Hatzifilippou E; Bouras E; Baloyannis S; Koutsouraki E
    J Int Med Res; 2019 May; 47(5):2187-2198. PubMed ID: 30982375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study.
    Azzimonti M; Preziosa P; Pagani E; Valsasina P; Tedone N; Vizzino C; Rocca MA; Filippi M
    J Neurol; 2023 Sep; 270(9):4296-4308. PubMed ID: 37202603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up.
    Lee AJ; Stark JH; Hayes SM;
    J Alzheimers Dis; 2024; 100(1):357-374. PubMed ID: 38875035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex.
    Tedone N; Preziosa P; Meani A; Pagani E; Vizzino C; Filippi M; Rocca MA
    Mol Psychiatry; 2023 Apr; 28(4):1783-1792. PubMed ID: 36806391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
    Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
    J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF β-amyloid predicts prognosis in patients with multiple sclerosis.
    Pietroboni AM; Caprioli M; Carandini T; Scarioni M; Ghezzi L; Arighi A; Cioffi S; Cinnante C; Fenoglio C; Oldoni E; De Riz MA; Basilico P; Fumagalli GG; Colombi A; Giulietti G; Serra L; Triulzi F; Bozzali M; Scarpini E; Galimberti D
    Mult Scler; 2019 Aug; 25(9):1223-1231. PubMed ID: 30084711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients.
    Pitteri M; Magliozzi R; Nicholas R; Ziccardi S; Pisani AI; Pezzini F; Marastoni D; Calabrese M
    Mult Scler; 2022 Apr; 28(5):768-777. PubMed ID: 34328817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Mattisi I; Bernardi V; Favaretto A; Perini P; Gallo P
    Mult Scler; 2010 Oct; 16(10):1220-8. PubMed ID: 20670981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
    Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
    J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
    Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.
    Fleischer V; Ciolac D; Gonzalez-Escamilla G; Grothe M; Strauss S; Molina Galindo LS; Radetz A; Salmen A; Lukas C; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kümpfel T; Zettl UK; Knop M; Tumani H; Wiendl H; Gold R; Bittner S; Zipp F; Groppa S; Muthuraman M;
    Ann Neurol; 2022 Feb; 91(2):192-202. PubMed ID: 34967456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis.
    Stellmann JP; Wanke N; Maarouf A; Gellißen S; Heesen C; Audoin B; Gold SM; Zaaraoui W; Poettgen J
    Neuroimage Clin; 2021; 30():102606. PubMed ID: 33744503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.